Identification and antimicrobial susceptibility testing of microorganisms from positive blood cultures by a combined lysis-centrifugation method with MALDI-TOF MS and VITEK2 System

Authors

  • Donatella Maria Rodio Dep. Public Health and Infectious Diseases, Sapienza University, Rome
  • Filomena Febbraro Department of Pediatrics, “Sapienza” University Rome
  • Gianluca Puggioni Department of Clinical Medicine, “Sapienza” University Rome
  • Camilla Paradisi Department of Public Health and Infectious Diseases, “Sapienza” University Rome
  • Flavia Stangherlin Department of Public Health and Infectious Diseases, “Sapienza” University Rome
  • Carla Prezioso Department of Public Health and Infectious Diseases, “Sapienza” University Rome
  • Guido Antonelli Department of Molecular Medicine and Pasteur Institute-Cenci Bolognetti Foundation, “Sapienza” University Rome
  • Maria Trancassini Department of Public Health and Infectious Diseases, “Sapienza” University Rome
  • Valeria Pietropaolo Dep. Public Health and Infectious Diseases, Sapienza University, Rome

Keywords:

Bacteremia, LCM, MALDI-TOF MS, VITEK®2, AST

Abstract

Background: Rapid identification and the application of antimicrobial susceptibility testing (AST) to microorganisms causing bloodstream infections is pivotal to guide antimicrobial therapy. This study aims to: 1) utilize the Lysis-Centrifugation Method (LCM) not only for identification of microorganisms from positive blood culture bottles, but also for direct AST full panel by Vitek®2 system (bioMérieux, Inc. France) and by disc diffusion plate (Kirby Bauer Method) and 2) analyze the accuracy of these combined methods.

Methods: 124 mono-microbial positive blood culture bottles were included in this study. An aliquot was subjected to LCM and used for the identification by the MALDI-TOF System. Moreover the microbial pellet was used for direct AST testing full panel by VITEK®2  system and by Kirby Bauer Method.

Results: 123 isolates were correctly identified to the species level and 1 isolate was identified to the genus level. Comparing the two utilized AST methods, it was observed that Gram-positive isolates showed an agreement rate of 96.6% (58/60). Enterococcus faecalis was the only microorganism with a major error rate of 0.6% (2/324) related to erythromycin. Among the Gram-negative, the overall agreement rate was 93.3 (56/60). Klebsiella pneumoniae, Escherichia coli and Enterobacter spp. were the major cause of minor error rates (0.6%, 4/709) and major error rates (1.1%, 8/709). Among the yeasts, results showed an agreement rate of 100% (4/4).

Conclusions: Our simple and cost-effective sample preparation method is very useful for rapid identification as well as AST of microorganisms directly from positive blood culture bottles in a clinical setting.

 

DOI: 10.21276/APALM.1212

References

1. Centers for Diseases Control and prevention (CDC), CDC/NHSN surveillance definitions for specific types of infections. http://www.cdc.gov/nhsn/PDFs/pscManual/17pscNosInfDef, 2014.
2. Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 2014; 42(8): 1749–55.
3. Bearman GML, Wenzel RP. Bacteremias: a leading cause of death Arch Med Res 2005; 36: 646–59.
4. Seifert H. The clinical importance of microbiological findings in the diagnosis and management of bloodstream infections. Clin Infect Dis 2009; 48: S238–45.
5. Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence 2014;5:4–11.
6. Opota O, Croxatto A, Prod'hom G, Greub G. Blood culture-based diagnosis of bacteraemia: state of the art. Clin Microbiol Infect 2015; 21(4): 313–22.
7. Buehler SS, Madison B, Snyder SR, Derzon JH, Cornish NE, Saubolle MA, et al. Effectiveness of practices to increase timeliness of providing targeted therapy for inpatients with bloodstream infections:a laboratory medicine best practices systematic review and meta-analysis. Clin Microbiol Rev 2016; 29(1): 59–103.
8. Hall M, Levant S, DeFrances C. Trends in inpatient hospital deaths: National Hospital Discharge Survey, 2000–2010. NCHS Data Brief 118. National Center for Health Statistics, Centers for Disease Control and Prevention, 2013; Atlanta, GA.
9. Liu V, Escobar GJ, Greene JD, Soule J, Whippy A, Angus DC, Iwashyna TJ. Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA 2014; 312: 90–2.
10. Beekmann SE, Diekema DJ, Doern GV. Determining the clinical significance of coagulase- negative staphylococci isolated from blood cultures. Infect Control Hosp Epidemiol 2005; 26(6): 559–66.
11. Micklos L. Do Needle-Free Connectors Prevent Catheter-Related Bloodstream Infections in Patients Receiving Hemodialysis Treatments Using Central Venous Catheters. Nephrol Nurs J 2015; 42(4): 383–6.
12. Machen A, Drake T, Wang YF. Same day identification and full panel antimicrobial susceptibility testing of bacteria from positive blood culture bottles made possible by a combined lysis-filtration method with MALDI-TOF VITEK mass spectrometry and the VITEK2 system. PLoS One 2014; 9(2): e87870.
13. Suarez S, Nassif X, Ferroni A. Applications of MALDI-TOF technology in clinical microbiology. Pathol Biol 2015; 63: 43–52.
14. Bizzini A, Greub G. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry, a revolution in clinical microbial identification. Clin Microbiol Infect 2010; 16: 1614–9.
15. Bizzini A, Durussel C, Bille J, Greub G, Prod’hom G. Performance of Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory. J Clin Microbiol 2010; 48: 1549–54.
16. Bizzini A, Jaton K, Romo D, Bille J, Prod’hom G, Greub G. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry as an alternative to 16S rRNA gene sequencing for identification of difficult-to-identify bacterial stains. J Clin Microbiol 2011; 49: 693–6.
17. Jo SJ, Park KG, Han K, Park DJ, Park YJ. Direct Identification and Antimicrobial Susceptibility Testing of Bacteria From Positive Blood Culture Bottles by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry and the Vitek 2 System. Ann Lab Med 2016; 36: 117–23.
18. Stevenson LG, Drake SK, Murray PR. Rapid identification of bacteria in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2009; 48: 444–7.
19. Kok J, Thomas LC, Olma T, Chen SC, Iredell JR. Identification of bacteria in blood culture broths using matrix-assisted laser desorption-ionization Sepsityperâ„¢ and time of flight mass spectrometry. PLoS One 2011; 6: e23285.
20. Schneiderhan W, Grundt A, Wörner S, Findeisen P, Neumaier M. Work flow analysis of around-the-clock processing of blood culture samples and integrated MALDI-TOF mass spectrometry analysis for the diagnosis of bloodstream infections. Clin Chem 2013; 59: 1649–56.
21. Lavergne RA, Chauvin P, Valentin A, Fillaux J, Roques-Malecaze C, Arnaud S, et al. An extraction method of positive blood cultures for direct identification of Candida species by Vitek MS matrix-assisted laser desorption ionization time of flight mass spectrometry. Med Mycol 2013; 51: 652–6.
22. Prod'hom G, Bizzini A, Durussel C, Bille J, Greub G. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for direct bacterial identification from positive blood culture pellets. J Clin Microbiol 2010; 48: 1481–3.
23. Monteiro J, Inoue FM, Lobo AP, Sugawara EK, Boaretti FM, Tufik S. Fast and reliable bacterial identification direct from positive blood culture using a new TFA sample preparation protocol and the Vitek®MS system. J Microbiol Methods 2015; 109: 157–9.
24. Febbraro F, Rodio DM, Puggioni G, Antonelli G, Pietropaolo V, Trancassini M. MALDI- TOF MS versus VITEK®2: Comparison of Systems for the Identification of Microorganisms Responsible for Bacteremia. Curr Microbiol 2016; 73(6): 843–50.
25. Harris P, Winney I, Ashhurst-Smith C, O'Brien M, Graves S. Comparison of Vitek MS (MALDI-TOF) to standard routine identification methods: an advance but no panacea. Pathology 2012; 4(6): 583–5.
26. Pavlovic M, Konrad R, Iwobi AN, Sing A, Busch U, Huber I. A dual approach employing MALDI-TOF MS and real-time PCR for fast species identification within the Enterobacter cloacae complex. FEMS Microbiol Lett 2012; 328(1): 46–53.
27. Patel R. Matrix-assisted laser desorption ionization-time of flight mass spectrometry in clinical microbiology. Clin Infect Dis. 2013; 57(4): 564–72.
28. Romero-Gómez MP, Gómez-Gil R, Paño-Pardo JR, Mingorance J. Identification and susceptibility testing of microorganism by direct inoculation from positive blood culture bottles by combining MALDI-TOF and Vitek-2 Compact is rapid and effective. J Infect 2012; 65: 513-20.
29. Wimmer JL, Long SW, Cernoch P, Land GA, Davis JR, Musser JM, et al. Strategy for rapid identification and antibiotic susceptibility testing of gram-negative bacteria directly recovered from positive blood cultures using the Bruker MALDI Biotyper and the BD Phoenix system. J Clin Microbiol 2012; 50(7): 2452–4.
30. Hayek SS, Abd TT, Cribbs SK, Anderson AM, Melendez A, Kobayashi M, et al. Rare Elizabethkingia meningosepticum meningitis case in an immunocompetent adult. Emerg Microbes Infec 2013; 2: e17.

Downloads

Published

12-04-2017

How to Cite

1.
Rodio DM, Febbraro F, Puggioni G, Paradisi C, Stangherlin F, Prezioso C, et al. Identification and antimicrobial susceptibility testing of microorganisms from positive blood cultures by a combined lysis-centrifugation method with MALDI-TOF MS and VITEK2 System. Ann of Pathol and Lab Med [Internet]. 2017 Apr. 12 [cited 2025 Feb. 5];4(2):A170-177. Available from: https://pacificejournals.com/journal/index.php/apalm/article/view/apalm1212

Issue

Section

Original Article